Total submissions: 9
| Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
|---|---|---|---|---|---|---|---|---|
| Genetic Services Laboratory, |
RCV000146769 | SCV000194091 | likely benign | not specified | 2013-02-08 | criteria provided, single submitter | clinical testing | |
| Prevention |
RCV000146769 | SCV000314046 | likely benign | not specified | criteria provided, single submitter | clinical testing | ||
| Labcorp Genetics |
RCV001709497 | SCV000749482 | benign | not provided | 2025-01-27 | criteria provided, single submitter | clinical testing | |
| Ambry Genetics | RCV002312967 | SCV000847368 | benign | Inborn genetic diseases | 2016-08-03 | criteria provided, single submitter | clinical testing | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
| Gene |
RCV001709497 | SCV001936682 | benign | not provided | 2015-03-03 | criteria provided, single submitter | clinical testing | |
| Genome- |
RCV003231174 | SCV002054844 | benign | Sotos syndrome | 2021-07-15 | criteria provided, single submitter | clinical testing | |
| Fulgent Genetics, |
RCV003231174 | SCV002799847 | likely benign | Sotos syndrome | 2021-08-17 | criteria provided, single submitter | clinical testing | |
| ARUP Laboratories, |
RCV003231174 | SCV004564661 | benign | Sotos syndrome | 2023-09-18 | criteria provided, single submitter | clinical testing | |
| Breakthrough Genomics, |
RCV001709497 | SCV005222543 | likely benign | not provided | criteria provided, single submitter | not provided |